Circulating biomarkers in malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive tumor strictly connected to asbestos exposure. Prognosis is dismal as diagnosis commonly occurs in advanced stage. Radiological screenings have not proven to be effective and also pathological diagnosis may be challenging. In the era of precision...
Main Authors: | Giuseppe Viscardi, Davide Di Natale, Morena Fasano, Marta Brambilla, Riccardo Lobefaro, Alessandro De Toma, Giulia Galli |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2020-12-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/etat/Article/100228 |
Similar Items
-
Mesothelin-targeted MRI for assessing migration, invasion, and prognosis in malignant pleural mesothelioma
by: Yilong Huang, et al.
Published: (2024-01-01) -
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
by: Laura Castelletti, et al.
Published: (2021-02-01) -
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
by: Duneesha de Fonseka, et al.
Published: (2018-08-01) -
Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma
by: Wafaa M. Ashour, et al.
Published: (2012-07-01) -
Assessment of the value of mesothelin in differentiating between different pleural malignancies by different interventional modalities
by: Mona M Ahmed, et al.
Published: (2022-01-01)